🇺🇸 FDA
Patent

US 7803386

Poly-gamma-glutamic conjugates for eliciting immune responses directed against bacilli

granted A61KA61K2039/55516A61K2039/6031

Quick answer

US patent 7803386 (Poly-gamma-glutamic conjugates for eliciting immune responses directed against bacilli) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Sep 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
42
CPC classes
A61K, A61K2039/55516, A61K2039/6031, A61K2039/6037, A61K2039/627